Ilirubinemia and cholelithiasis in hemoglobinopathy sufferers. PLoS One 2013;8:e77681 ?Chaar V

Haematologica 2005;90:188?9 Chaouch L, Talbi E, Moumni I, Ben MedChemExpress MDL-29951 Chaabene A, Kalai M, Chaouachi D, Mallouli F, Ghanem A, Abbes S. Eur J Haematol 2012;88:61? Adams R, McKie V, Nichols F, Carl E, Zhang DL, McKie K, Figueroa R, Litaker M, Thompson W, Hess D. The usage of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 1992;326:605?0 Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, Abboud M, Gallagher D, Kutlar A, Nichols FT, Bonds DR, Brambilla D. Prevention of a initially stroke by transfusions in young children with sickle cell anemia and abnormal final results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5?1 McCavit TL, Xuan L, Zhang S, Flores G, Quinn CT. National trends in incidence prices of hospitalization for stroke in children with sickle cell disease. Pediatr Blood Cancer 2013;60:823? Ware RE, Davis BR, Schultz WH, Brown RC, Aygun B, Sarnaik S, Odame I, Fuh B, George A, Owen W, Luchtman-Jones L, Rogers ZR, Hilliard L, Gauger C, Piccone C, Lee MT, Kwiatkowski JL, Jackson S, Miller ST, Roberts C, Heeney MM, Kalfa TA, Nelson S, Imran H, Nottage K, Alvarez O, Rhodes M, Thompson AA, Rothman JA, Helton KJ, Roberts D, Coleman J, Bonner MJ, Kutlar A, Patel N, Wood J, Piller L, Wei P, Luden J, Mortier NA, Stuber SE, Luban NLC, Cohen AR, Pressel S, Adams RJ. Hydroxycarbamide versus chronic transfusion for upkeep of transcranial Doppler flow velocities in kids with sickle cell anaemia-TCD with transfusions altering to hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. Lancet 2016;387:661?0 Niss O, Quinn CT, Lane A, Everyday J, Khoury PR, Bakeer N, Skalski E, Kimball TR, Towbin JA, Malik P, Taylor MD.Ilirubinemia and cholelithiasis in hemoglobinopathy patients. PLoS A single 2013;eight:e77681 ?Chaar V, Keclard L, Diara JP, Leturdu C, Elion J, Krishnamoorthy R, Clayton J, Romana M. Association of UGT1A1 polymorphism with title= fnhum.2013.00464 prevalence and age at onset of cholelithiasis in sickle cell anemia. Haematologica 2005;90:188?9 Chaouch L, Talbi E, Moumni I, Ben Chaabene A, Kalai M, Chaouachi D, Mallouli F, Ghanem A, Abbes S. title= 2750858.2807526 Early complication in sickle cell anemia youngsters as a result of A(TA)nTAA polymorphism at the promoter of UGT1A1 gene. Dis Markers 2013;35:67?2 Quinn CT, Miller ST. Danger factors and prediction of outcomes in children and adolescents who've sickle cell anemia. Hematol Oncol Clin N Am 2004;18:1339?four Strimbu K, Tavel JA. What are biomarkers? Curr Opin HIV AIDS 2010;five:463? Hryniewicz-Jankowska A, Choudhary PK, Ammann LP, Quinn CT, Goodman SR. Monocyte protein signatures of disease severity in sickle cell anemia. Exp Biol Med (Maywood) 2009;234:210? Miller ST, Sleeper LA, Pegelow CH, Enos LE, Wang WC, Weiner SJ, Wethers DL, Smith J, Kinney TR. Prediction of adverse outcomes in children with sickle cell illness. N Engl J Med 2000;342:83? van den Tweel XW, van der Lee JH, Heijboer H, Peters M, Fijnvandraat K. Development and validation of a pediatric severity index for sickle cell sufferers. Am J Hematol 2010;85:746?1 title= 1472-6920-13-86 ?Joly P, Pondarre C, Bardel C, Francina A, Martin C.